NO991205L - Aktivitetsforsterkende middel for glutationreduktase som inneholder troglitazon - Google Patents

Aktivitetsforsterkende middel for glutationreduktase som inneholder troglitazon

Info

Publication number: NO991205L
Authority: NO; Norway
Prior art keywords: glutathione reductase; activity; enhancing agent; reductase containing; containing troglitazone
Prior art date: 1996-09-12

Application number

NO991205A

Other languages

English (en)

Norwegian (no)

Other versions

NO991205D0 (no

Inventor

Tomihisa Yokoyama

Toshihiko Fujiwara

Hiroyoshi Horikoshi

Shinji Yoshioka

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-12

Filing date

1999-03-11

Publication date

1999-05-11

1999-03-11 Application filed by Sankyo Co filed Critical Sankyo Co

1999-03-11 Publication of NO991205D0 publication Critical patent/NO991205D0/no

1999-05-11 Publication of NO991205L publication Critical patent/NO991205L/no

Links

108010063907 Glutathione Reductase Proteins 0.000 title abstract 3
102100036442 Glutathione reductase, mitochondrial Human genes 0.000 title abstract 3
GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 title abstract 2
229960001641 troglitazone Drugs 0.000 title abstract 2
GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 title abstract 2
239000003623 enhancer Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO991205A 1996-09-12 1999-03-11 Aktivitetsforsterkende middel for glutationreduktase som inneholder troglitazon NO991205L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP24191096		1996-09-12
PCT/JP1997/003199 WO1998010760A1 (fr)	1996-09-12	1997-09-11	Potentialisateur d'activite de glutathione-reductase contenant de la troglitazone

Publications (2)

Publication Number	Publication Date
NO991205D0 NO991205D0 (no)	1999-03-11
NO991205L true NO991205L (no)	1999-05-11

Family

ID=17081372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991205A NO991205L (no)	1996-09-12	1999-03-11	Aktivitetsforsterkende middel for glutationreduktase som inneholder troglitazon

Country Status (12)

Country	Link
EP (1)	EP0958818A1 (cs)
KR (1)	KR20000036035A (cs)
CN (1)	CN1235543A (cs)
AU (1)	AU723354B2 (cs)
CA (1)	CA2265656A1 (cs)
CZ (1)	CZ74199A3 (cs)
HU (1)	HUP0002941A3 (cs)
ID (1)	ID21778A (cs)
IL (1)	IL128771A0 (cs)
NO (1)	NO991205L (cs)
NZ (1)	NZ334577A (cs)
WO (1)	WO1998010760A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP2001002036A0 (en) *	1998-07-21	2001-03-31	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing apoptosis.
US6613785B2 (en)	1998-07-21	2003-09-02	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
MA26662A1 (fr) *	1998-07-21	2004-12-20	Smithkline Beecham Plc	Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation
WO2000007582A2 (en) *	1998-08-06	2000-02-17	Warner-Lambert Company	Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
US6379664B1 (en)	1998-09-29	2002-04-30	Board Of Regents University Of Nebraska-Lincoln	Composition and method for the prevention and treatment of oxidative damage in ocular tissues
AU3073600A (en) *	1999-01-19	2000-08-07	Sankyo Company Limited	Inhibitor for nerve cell death due to glutamic acid cytotoxicity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
JPS6136284A (ja) *	1984-07-27	1986-02-20	Sankyo Co Ltd	チアゾリジン誘導体およびその製造方法
JPH0653738B2 (ja) *	1985-02-26	1994-07-20	三共株式会社	チアゾリジン誘導体
JPS62234085A (ja) *	1985-12-18	1987-10-14	Sankyo Co Ltd	チアゾリジン誘導体を有効成分とする糖尿病性合併症治療剤
WO1988000182A1 (fr) *	1986-07-07	1988-01-14	Teijin Limited	ESTER D'ETHYLE DE gamma-L-GLUTAMYL-L-CYSTEINE ET MEDICAMENT LE CONTENANT EN TANT QU'INGREDIENT ACTIF
JP2553090B2 (ja) *	1987-07-21	1996-11-13	帝人株式会社	組織グルタチオンレベル向上剤
JPH05202042A (ja) *	1992-01-24	1993-08-10	Sankyo Co Ltd	糖尿病性合併症治療剤
JPH0651189A (ja) *	1992-08-04	1994-02-25	Kyocera Corp	オートフォーカス一眼レフカメラの近接撮影機構
JP2945220B2 (ja) *	1992-10-23	1999-09-06	旭カーボン株式会社	ハード系高ストラクチャーカーボンブラック

1997
- 1997-09-11 ID IDW990076A patent/ID21778A/id unknown
- 1997-09-11 CN CN97199335A patent/CN1235543A/zh active Pending
- 1997-09-11 WO PCT/JP1997/003199 patent/WO1998010760A1/ja not_active Ceased
- 1997-09-11 KR KR1019997002023A patent/KR20000036035A/ko not_active Withdrawn
- 1997-09-11 CZ CZ99741A patent/CZ74199A3/cs unknown
- 1997-09-11 AU AU42195/97A patent/AU723354B2/en not_active Ceased
- 1997-09-11 IL IL12877197A patent/IL128771A0/xx unknown
- 1997-09-11 EP EP97940341A patent/EP0958818A1/en not_active Withdrawn
- 1997-09-11 CA CA002265656A patent/CA2265656A1/en not_active Abandoned
- 1997-09-11 NZ NZ334577A patent/NZ334577A/en unknown
- 1997-09-11 HU HU0002941A patent/HUP0002941A3/hu unknown
1999
- 1999-03-11 NO NO991205A patent/NO991205L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0002941A2 (hu)	2001-08-28
AU723354B2 (en)	2000-08-24
NZ334577A (en)	2001-03-30
WO1998010760A1 (fr)	1998-03-19
EP0958818A1 (en)	1999-11-24
NO991205D0 (no)	1999-03-11
CA2265656A1 (en)	1998-03-19
KR20000036035A (ko)	2000-06-26
AU4219597A (en)	1998-04-02
IL128771A0 (en)	2000-01-31
CZ74199A3 (cs)	1999-07-14
ID21778A (id)	1999-07-22
CN1235543A (zh)	1999-11-17
HUP0002941A3 (en)	2001-11-28

Similar Documents

Publication	Publication Date	Title
HRP20000494B1 (en)	2009-02-28	Pharmaceutically active morpholinol
NO20002173L (no)	2000-06-05	Pleuromutilin-derivater som antimikrobielle midler
DK0533781T3 (da)	1997-07-07	3-aryl-2-hydroxypropionsyrederivater og -analoger som hypoglykæmiske midler
AU1319597A (en)	1997-08-20	Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
SG165987A1 (en)	2010-11-29	Substituted benzoxazoles and analogues as estrogenic agents
DK0698393T3 (da)	2002-08-05	3-/-menthoxypropan-1,2-diol som solubiliseringsmiddel og præparat til udvortes brug, der indeholder samme
NO2016024I2 (no)	2016-12-15	Farmasøytisk blanding eller assosisjon som inneholder som aktive ingredienser: (1) ceftazidim eller et salt derav, og (2) avibaktam eller et farmasøytisk akseptabelt salt derav
AU2447301A (en)	2001-07-09	Early warning mechanism for enhancing enterprise availability
MXPA03000136A (es)	2004-09-13	Derivados anticonvulsivos utiles para prevenir el desarrollo de la diabetes mellitus de tipo ii o del sindromex.
ZA200201509B (en)	2003-04-30	Pharmaceutically active sulfonamide derivatives.
FI912713A7 (fi)	1991-12-08	Armbandsur som mottar via radio saend information.
MX9204233A (es)	1994-06-30	Inhibidores de proteasa retroviral.
AU7722296A (en)	1997-06-05	Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
NO20004047D0 (no)	2000-08-11	FremgangsmÕte for mottaking samt mottaker som benytter flere forskjellige transportformater
NO963117D0 (no)	1996-07-25	Indol-derivater som 5-HT1-agonister
NO991205L (no)	1999-05-11	Aktivitetsforsterkende middel for glutationreduktase som inneholder troglitazon
ATE267602T1 (de)	2004-06-15	2-methyl-thieno-benzodiazepin-formulierung
NO2010004I1 (no)	2010-03-22	0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon
NO974934L (no)	1998-04-27	10,13,15-trioksatrisyklo£9.2.1.19.6\|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
DE69708340D1 (de)	2001-12-20	Arylsulfonylimidazolon-derivate als antitumormittel
NO20021040D0 (no)	2002-03-01	Substituerte N-fenyl- 2-hydroksy-2-metyl-3,3,3- trifluoropropanamid-derivater som eleverer puruvatdehydrogenase-aktivitet
AU3386199A (en)	1999-10-25	N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
ES2191241T3 (es)	2003-09-01	Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
CO5021190A1 (es)	2001-03-27	Agentes terapeuticos
PT1128829E (pt)	2005-07-29	Associacao de riluzole e de alfa-tocoferol

Legal Events

Date	Code	Title	Description
2002-06-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application